Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07FND
|
|||
| Former ID |
DIB009460
|
|||
| Drug Name |
Nabi-HB
|
|||
| Synonyms |
Reformulated HBV therapy, Nabi; Hepatitis B virus immune globulin (intramuscular), Nabi; H-BIG 5%iv formulation, Nabi
Click to Show/Hide
|
|||
| Indication | Hepatitis B virus infection [ICD-11: 1E51.0; ICD-10: B18.1] | Approved | [1] | |
| Company |
Nabi Biologics
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Hepatitis B virus Large envelope protein (HBV S) | Target Info | Modulator | [1], [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 2 | Hepatitis B Immune Globulin (Human) Nabi-HB . US Food and Drug Administration report. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.